Maxim Group Initiates Coverage On Genelux with Buy Rating, Announces Price Target of $40
Portfolio Pulse from Benzinga Newsdesk
Maxim Group analyst Jason McCarthy has initiated coverage on Genelux (NASDAQ:GNLX) with a Buy rating and a price target of $40.
September 12, 2023 | 1:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Genelux has been initiated with a Buy rating by Maxim Group, with a price target of $40.
The Buy rating and price target of $40 by Maxim Group indicates a positive outlook for Genelux. This could potentially attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100